×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ICCC – immucell corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ICCC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/13
05:00 pm
iccc
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors [Yahoo! Finance]
Medium
Report
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors [Yahoo! Finance]
4/13
04:38 pm
iccc
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
Medium
Report
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
4/8
05:37 pm
iccc
Stocks to watch after market on Wednesday: ICCC, COST, STZ [Seeking Alpha]
Medium
Report
Stocks to watch after market on Wednesday: ICCC, COST, STZ [Seeking Alpha]
4/8
05:00 pm
iccc
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results [Yahoo! Finance]
Medium
Report
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results [Yahoo! Finance]
4/8
04:05 pm
iccc
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
High
Report
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
4/7
06:06 pm
iccc
ImmuCell (ICCC) was downgraded by Weiss Ratings from "hold (c-)" to "sell (d-)".
Medium
Report
ImmuCell (ICCC) was downgraded by Weiss Ratings from "hold (c-)" to "sell (d-)".
3/18
04:05 pm
iccc
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
Low
Report
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
3/7
07:03 pm
iccc
ImmuCell Corp (ICCC) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges [Yahoo! Finance]
Low
Report
ImmuCell Corp (ICCC) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/16
04:04 pm
iccc
Form 4 IMMUCELL CORP /DE/ For: Apr 15 Filed by: Turner Kathy V
Medium
Report
Form 4 IMMUCELL CORP /DE/ For: Apr 15 Filed by: Turner Kathy V
4/16
04:02 pm
iccc
Form 4 IMMUCELL CORP /DE/ For: Apr 15 Filed by: Tomsche David Scott
Medium
Report
Form 4 IMMUCELL CORP /DE/ For: Apr 15 Filed by: Tomsche David Scott
4/16
03:59 pm
iccc
Form 4 IMMUCELL CORP /DE/ For: Apr 15 Filed by: Basse Gloria F
Low
Report
Form 4 IMMUCELL CORP /DE/ For: Apr 15 Filed by: Basse Gloria F
4/16
03:58 pm
iccc
Form 4 IMMUCELL CORP /DE/ For: Apr 15 Filed by: Wainman Paul R
Low
Report
Form 4 IMMUCELL CORP /DE/ For: Apr 15 Filed by: Wainman Paul R
4/14
04:42 pm
iccc
Form PRE 14A IMMUCELL CORP /DE/ For: Jun 11
Low
Report
Form PRE 14A IMMUCELL CORP /DE/ For: Jun 11
4/14
03:40 pm
iccc
Form 4 IMMUCELL CORP /DE/ For: Apr 16 Filed by: Gathagan Bryan K.
Low
Report
Form 4 IMMUCELL CORP /DE/ For: Apr 16 Filed by: Gathagan Bryan K.
4/14
03:39 pm
iccc
Form 4 IMMUCELL CORP /DE/ For: Apr 16 Filed by: Wainman Paul R
Low
Report
Form 4 IMMUCELL CORP /DE/ For: Apr 16 Filed by: Wainman Paul R
4/14
03:38 pm
iccc
Form 4 IMMUCELL CORP /DE/ For: Apr 16 Filed by: Tomsche David Scott
Low
Report
Form 4 IMMUCELL CORP /DE/ For: Apr 16 Filed by: Tomsche David Scott
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/21
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Year Ended December 31, 2019
6.9%
5/7 ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019 5.8%
4/2 ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020 3.5%
2/19 ImmuCell Corporation (ICCC) CEO Michael Brigham on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.5%
8/6 ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019 2.6%
2/13 ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019 2.4%
4/14 ImmuCell Receives $938,000 in Support under the Paycheck Protection Program 2.0%
9/11 ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain™ 1.9%
4/28 Form DEF 14A IMMUCELL CORP /DE/ For: Jun 10 1.5%
1/22 Form 8-K IMMUCELL CORP /DE/ For: Jan 21 1.2%
5/7 ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019 5.8%
4/2 ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020 3.5%
2/19 ImmuCell Corporation (ICCC) CEO Michael Brigham on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.5%
8/6 ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019 2.6%
2/13 ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019 2.4%
4/14 ImmuCell Receives $938,000 in Support under the Paycheck Protection Program 2.0%
9/11 ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain™ 1.9%
4/28 Form DEF 14A IMMUCELL CORP /DE/ For: Jun 10 1.5%
1/22 Form 8-K IMMUCELL CORP /DE/ For: Jan 21 1.2%
TOP News Decliners
3/2
Form 4 IMMUCELL CORP /DE/ For: Feb 27 Filed by: Tomsche David Scott
-10.1%
2/18 Form 8-K IMMUCELL CORP /DE/ For: Feb 18 -8.5%
3/11 ImmuCell Announces Refinancing of its Bank Debt -7.4%
5/10 Form DEFR14A IMMUCELL CORP /DE/ -3.3%
9/11 Form 8-K IMMUCELL CORP /DE/ For: Sep 05 -3.3%
9/5 ImmuCell Co. (NASDAQ: ICCC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.2%
3/27 Form S-8 IMMUCELL CORP /DE/ -3.0%
5/14 ImmuCell Corporation's (ICCC) CEO Michael Brigham on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -2.0%
12/12 Form 4 IMMUCELL CORP /DE/ For: Dec 09 Filed by: Brockmann Bobbi Jo -1.8%
1/28 Form SC 13G IMMUCELL CORP /DE/ Filed by: WELLINGTON MANAGEMENT GROUP LLP -1.6%
2/18 Form 8-K IMMUCELL CORP /DE/ For: Feb 18 -8.5%
3/11 ImmuCell Announces Refinancing of its Bank Debt -7.4%
5/10 Form DEFR14A IMMUCELL CORP /DE/ -3.3%
9/11 Form 8-K IMMUCELL CORP /DE/ For: Sep 05 -3.3%
9/5 ImmuCell Co. (NASDAQ: ICCC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.2%
3/27 Form S-8 IMMUCELL CORP /DE/ -3.0%
5/14 ImmuCell Corporation's (ICCC) CEO Michael Brigham on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -2.0%
12/12 Form 4 IMMUCELL CORP /DE/ For: Dec 09 Filed by: Brockmann Bobbi Jo -1.8%
1/28 Form SC 13G IMMUCELL CORP /DE/ Filed by: WELLINGTON MANAGEMENT GROUP LLP -1.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: